Basilea Pharmaceutica Ltd (0QNA)
Market Closed
19 Jun, 15:30
LSE 
50. 70
CHF +0
+0.0015%
- Market Cap
7.96 P/E Ratio
20% Div Yield
1,122 Volume
2.9 Eps
50.7 CHF
Previous Close Want to track 0QNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
0QNA Earnings Reports FAQ
What is the earnings per share (EPS) for 0QNA?
The current EPS is 2.9.
What is the company's earnings growth rate?
Basilea Pharmaceutica Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Basilea Pharmaceutica Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Basilea Pharmaceutica Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 0QNA at this time, as Basilea Pharmaceutica Ltd has no recent EPS data to calculate it.
